Currently, there is no official contraindication listed in the Summary of Product Characteristics (SmPC) that specifically prohibits the use of semaglutide in patients with inflammatory bowel disease (IBD), including Crohn's disease

Potential Risks and Considerations Even setting aside regulatory status, any consideration of growth hormone stimulating compounds requires awareness of potential risks that appear in the clinical and safety literature: Water retention and edema Joint pain (arthralgia), which is a known side effect of GH elevation Potential impact on insulin sensitivity GH affects glucose metabolism Theoretical concerns about stimulating GH in individuals with undiagnosed malignancies (GH is a growth factor) Unknown long-term effects from extended use in healthy adults Quality and purity concerns when obtained outside regulated pharmaceutical channels These considerations underscore why any decision regarding peptide therapy must involve a physician who can review individual medical history, contraindications, and current evidence not a wellness clinic, online pharmacy, or influencer recommendation
This article discusses the precautions as well as contradictions that are associated with semaglutide use
Ingredients: Plant sterols, inulin, phenolic glycosides, flavonoids, phylloquinone (vitamin K1), rosae extract, pruni cum inulin extract, 24-methylcholesta-5,22-dien-3 beta-ol, stigmast-5-en-3-ol, 24alpha-methylcholesterol, dodecahydro-1H-cyclopenta[a]phenanthren-3-ol Recommended Use: As a dietary supplement, take 1 capsule daily after meals
Sigma-Aldrich Inc
Its shame